Australia Patent Office Accepts Patent for RESP3000
Respiratorius announces that the Australian Patent Office issued a Notice of Acceptance for the patent application for RESP3000 series, designed for use in cardiovascular diagnostics with PET-camera. The priority date for the patent application is from December 2011, which means that the patent is in force until December 2031.The substances in the RESP3000 series specifically binds to mitochondria, and since the heart muscle is rich in mitochondria allowing for high contrast and detailed PET images, which is also confirmed in the completed "proof of concept" study. Markers to PET-cameras